OneSource Speci.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE013P01021
  • NSEID: ONESOURCE
  • BSEID: 544292
INR
1,614.10
10.7 (0.67%)
BSENSE

Nov 20

BSE+NSE Vol: 2.3 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039523,
    "name": "OneSource Speci.",
    "stock_name": "OneSource Speci.",
    "full_name": "OneSource Specialty Pharma Ltd",
    "name_url": "stocks-analysis/onesource-speci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,614.10",
    "chg": 10.7,
    "chgp": "0.67%",
    "dir": 1,
    "prev_price": "1,603.40",
    "mcapval": "18,384.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544292,
    "symbol": "ONESOURCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE013P01021",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "2.3 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/onesource-speci-10039523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "OneSource Specialty Pharma’s Mixed Week: +0.04% Price, +1.55% Sensex Tell the Story",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/onesource-specialty-pharmas-mixed-week-004-price-155-sensex-tell-the-story-4269912",
        "imagepath": "",
        "date": "2026-11-21 10:01:43",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Upgrade to Hold on technical and financial improvements</p>\n                    <p><strong>16 Nov:</strong> Technical momentum shifts to sideways trend amid mixed signals</p>\n                    <p><strong>18 Nov:</strong> Downgrade to Sell reflecting concerns on profitability and leverage</p>\n                    <p><strong>20 Nov:</strong> Week closes at Rs.1,614.10 (+0.04%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,613.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"..."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/onesource-specialty-pharma-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4267731",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/OneSourceSpecia_mojoScore_4267731.png",
        "date": "2026-11-19 08:40:23",
        "description": "OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell by MarketsMojo as of 18 Nov 2026. This decision follows a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals, reflecting a complex interplay of strong operational growth but persistent financial and technical weaknesses."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Upgraded to Hold on Technical and Financial Improvements",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/onesource-specialty-pharma-ltd-upgraded-to-hold-on-technical-and-financial-improvements-4263299",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/OneSourceSpecia_mojoScore_4263299.png",
        "date": "2026-11-16 08:54:32",
        "description": "OneSource Specialty Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable shift in technical indicators and improved financial performance. Despite lingering concerns over management efficiency and debt servicing, the company’s recent quarterly results and stabilising technical trends have prompted a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/onesource-specialty-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-4263160",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/OneSourceSpecia_technicaldot_4263160.png",
        "date": "2026-11-16 08:04:44",
        "description": "OneSource Specialty Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a slight dip in daily price, the stock’s weekly and monthly signals reveal a nuanced picture for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "OneSource Specialty Pharma Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/onesource-specialty-pharma-ltd-is-rated-sell-4253887",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/OneSourceSpecia_mojoScore_4253887.png",
        "date": "2026-11-06 10:11:34",
        "description": "OneSource Specialty Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "OneSource Specialty Pharma Surges 17.30%: Key Drivers Behind the Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/onesource-specialty-pharma-surges-1730-key-drivers-behind-the-rally-4245246",
        "imagepath": "",
        "date": "2026-10-31 10:00:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock opens at Rs.1,396.30 with a 4.77% gain</p>\n                    <p><strong>27 Oct:</strong> Intraday high of Rs.1,605.00 and 13.96% daily surge on strong quarterly results</p>\n                    <p><strong>28 Oct:</strong> Continued robust trading with 2.96% gain amid mixed technical signals</p>\n                    <p><strong>29 Oct:</strong> Minor declines despite Sensex rally</p>\n                    <p><strong>30 Oct:</strong> Week closes at Rs.1,563.25, down 0.41% on the day but up 17.30% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div c..."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Sees Robust Trading Activity Amid Strong Gains",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/onesource-specialty-pharma-ltd-sees-robust-trading-activity-amid-strong-gains-4241704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/OneSourceSpecia_most_active_equities_by_value_4241704.png",
        "date": "2026-10-28 10:00:18",
        "description": "OneSource Specialty Pharma Ltd (ONESOURCE) has emerged as one of the most actively traded stocks by value on 28 Oct 2026, demonstrating strong investor interest and notable price appreciation. The pharmaceutical and biotechnology company’s shares have recorded significant volume and value turnover, outperforming its sector and broader market indices amid rising institutional participation and sustained buying momentum."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/onesource-specialty-pharma-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-4241557",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/OneSourceSpecia_technicaldot_4241557.png",
        "date": "2026-10-28 08:06:01",
        "description": "OneSource Specialty Pharma Ltd has experienced a notable shift in price momentum, reflected in a 13.96% surge in its share price to ₹1,591.25, signalling a potential change in technical trends. Despite this rally, the company’s overall technical indicators present a complex picture, with some metrics suggesting mild bearishness while others hint at emerging bullish tendencies."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Reports Very Positive Quarterly Financial Performance Amid Market Volatility",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/onesource-specialty-pharma-ltd-reports-very-positive-quarterly-financial-performance-amid-market-volatility-4241187",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/OneSourceSpecia_fintrenddot_4241187.png",
        "date": "2026-10-27 15:00:11",
        "description": "OneSource Specialty Pharma Ltd has delivered a remarkable financial performance in the quarter ended September 2026, marking a significant improvement from its previous trend. The company’s latest results reveal record-breaking revenue and profit metrics, signalling a very positive shift in its financial trajectory amid a challenging Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 66,
    "sid": "10039523",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/onesource-specialty-pharma-10039523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "17-Nov-2026",
      "details": "Intimation of resignation of Senior Management Personnel",
      "source": "BSE"
    },
    {
      "caption": "The Company Is Informing The Exchange About Participation In Jefferies Global Healthcare Conference.",
      "datetime": "05-Nov-2026",
      "details": "Onesource Specialty Pharma Limited has informed the Exchange about the Participation in Jefferies Global Healthcare Conference to be held from November 16 2026 to November 19 2026 in London.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "30-Oct-2026",
      "details": "OneSource receives USFDA EIR with VAI Classification Marking completion of Inspection process at its Sterile Product Division (SPD) Facility in Bengaluru.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Change in Management

17-Nov-2026 | Source : BSE

Intimation of resignation of Senior Management Personnel

The Company Is Informing The Exchange About Participation In Jefferies Global Healthcare Conference.

05-Nov-2026 | Source : BSE

Onesource Specialty Pharma Limited has informed the Exchange about the Participation in Jefferies Global Healthcare Conference to be held from November 16 2026 to November 19 2026 in London.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

30-Oct-2026 | Source : BSE

OneSource receives USFDA EIR with VAI Classification Marking completion of Inspection process at its Sterile Product Division (SPD) Facility in Bengaluru.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available